Decrease in Fracture Rate with Mandatory Bone-protecting Agents in the EORTC 1333/PEACE-3 Trial Comparing Radium-223 Combined with Enzalutamide Versus Enzalutamide Alone: A Safety Analysis

Silke Gillessen, Bertrand Tombal, Fabio Turco, Ananya Choudhury, Alejo Rodríguez‐Vida, Enrique Gallardo, Pedro Isaacsson Velho, Franco Nolè, Felipe Melo Cruz, Yohann Loriot, Ray McDermott, Thierry Roumeguère, Gedske Daugaard, Rosley Yamamura, Emmanuelle Bompas, Pablo Maroto, Manuel Herrero Polo, Karine Martins da Trindade, Daniel D’Almeida Preto, Iwona Skoneczna, Frédéric Lecouvet, Corneel Coens, Béatrice Fournier, Fred Saad